TCL Archive Funding Opportunities: HHMI Commits $300M To Support Early Career Scientists. March 21, 2008
TCL Archive In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored August 16, 1974
TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013
